Dr. Rebecca Cunningham
Critical Care Scientist, NISTAR, Belfast Health and Social Care Trust
Critical care is a high technology area and utilises applied science. What defines a Critical Care Scientist (CCS) as a unique professional is, the combination of equipment management, patient/technology interface and training of other professionals. Rebecca as a healthcare scientist requires a significant depth and breadth of knowledge. Her primary role is to provide the scientific and technological services and solutions to support organ function and maintain life.
With the patient’s life being dependent upon the application of science, Rebecca utilises monitoring and diagnostic procedures, including Point of Care Testing, plus organ support technologies and therapies, to diagnose and treat a wide variety of conditions, including trauma and multi organ failure. This is further underpinned by the bedside training and supervision of staff in the use, application and the management of the technologies that are required during a life-threatening event.
Rebecca is responsible for the supply, efficacy, quality assurance and application of critical care technologies. This includes the introduction of new technology, which leads to improved quality of care for critically ill patients at all levels of dependency. Rebecca may be employed in any location where a patient requiring critical care is to be found, this includes the Intensive Care Unit, Operating Theatres, MRI, CT, Emergency Department and in areas of physiological extremes or stress.
Rebecca holds a BSc in Biomedical Science and a PhD in Physiology from Queens University Belfast. She is a member of “The Society of Critical Care Technologies.” The Society is an active member of the Academy for Healthcare Sciences (AHCS) and the National School of Healthcare Science (NSHCS); representing Critical Care Scientists in the provision of educational, professional pathways and developing standards of best practice.
3D mammosphere culture of breast epithelial cell line MCF10A.
Courtesy of Dr. Emer Bourke, NUI Galway
Phospho-Akt expression and localisation
Mediated by VEGF in A549 lung cancer cells. Visualised by high content image analysis.
Metaphase chromosome spread of Jurkat T-lymphoma cells
Apoptosis assessment of SKMES-1 lung cancer cells
Using a multiparameter apoptosis staining kit, showing cell nuclei (blue), actin (green) and mitochondrial activity (orange).
Mitotic Chronic Myelogenous Leukaemia K562 Cells
Cell to Cell Tweeting
Via nanoparticles (red) in Triple Negative Breast Cancer (TNBC)
Courtesy of Sinéad Lindsay, UCD Conway Institute of Biomolecular and Biomedical Research, University College Dublin (UCD) Ireland.
Confocal Microscopy Analysis
Of phospho-Akt expression in H460 lung cancer cells in response to hypoxia (0.5% O2).
EACR Free Membership
The IACR is an affiliated national society and its members benefit from full membership of the EACR.
IACR 2022 Conference Registration
Please register by completing our online form.
IACR 2022 Conference Accommodation
B&B Rates and how to get to Radisson Blu Hotel, Cork
for Cancer Research
9A Coolkill, Sandyford
Dublin 18, Ireland
+353 (0)295 8859
Irish Association for Cancer Research (IACR) is a registered charity on the Register of Charitable Organisations, Charities Regulator, 3 George's Dock, IFSC, Dublin 1, D01 X5X0, Ireland.
Registered Charity Number (RCN): 20030117.
©Design by LetterEleven